Estimation of the prevalence, incidence, comorbidities and direct costs associated to stroke patients requiring care in an area of the Spanish population;Estimación de la prevalencia, incidencia, comorbilidades y costes directos asociados en pacientes que demandan atención por ictus en un ámbito poblacional español

Revista de Neurologia

Volumn 46, Issue 7, 2008, Pages 397-405

  Fernandez De Bobadilla J ^d   Sicras Mainar, Antoni ^a   Navarro Artieda, R ^b   Planas Comes, A ^c   Soto Alvarez J ^d   Sanchez Maestre C ^e   Alvarez Martin C ^d   Ezpeleta Echevarri, D ^f  

^a Badalona Serveis Assistencials SA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c Hospital Municipal de Badalona   (Spain)

^d PFIZER INC   (United States)

^e Instituto Euroclin   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Cardiovascular event; Co morbidities; Direct costs; Spanish population; Stroke

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ALCOHOL CONSUMPTION; ANALYSIS OF COVARIANCE; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHARMACY; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; SMOKING; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 44449089884     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4607.2008052     Document Type: Article

References (48)

1. Casado D. Los efectos del envejecimiento demográfico sobre el gasto sanitario: mitos y realidades. Gac Sanit 2000; 15: 154-63.
2. Sánchez-Sánchez C. Impacto sociosanitario de las enfermedades neurológicas en España. URL: http://www.feeneurologia. com/pdf/impact-sociosanitarioenferneurologicas.pdf [16.06.2007].
3. Álvarez-Sabín J, Molina C, Montaner J, Arenillas J, Pujadas F, Huertas R, et al. Beneficios clínicos de la implantación de un sistema de atención especializada y urgente del ictus. Med Clin (Barc) 2004; 122: 528-31.
4. Murillo-Cabezas F, Jiménez-Hernández MD, en representación de los miembros del grupo del proyecto PLACA. Iniciativa multidisciplinaria para la mejora de la atención en el ataque cerebrovascular (ictus) en Andalucía: proyecto PLACA. Rev Clin Esp 2005; 205: 226-9.
5. Bonita R, Mendis S, Truelsen T, Bogousslassky J, Toole J, Yatsu F. The Global Stroke Initiative. Lancet Neurol 2004; 3: 391-3.
6. Truelsen T, Piechowski-Józwiak B, Bonita R, Mathers C, Bogousslavsky J, Boysen G. Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol 2006; 13: 81-98.
7. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003; 2: 43-53.
8. Boix R, del Barrio JL, Saz P, Reñé R, Manubens JM, Lobo A, et al. Stroke prevalence among the Spanish elderly: an analysis based on screening surveys. BMC Neurol 2006; 6: 36.
9. Martí-Vilalta JL, Arboix A. The Barcelona Stroke Registry. Eur Neurol 1999; 41: 135-42.
10. Otero-Palleiro MM, Barbagelata-López C. Etiologic subtypes of ischemic stroke in young adults aged 18 to 45 years: a study of a series of 93 patients. Rev Clin Esp 2007; 207: 158-65.
11. Beltrán-Blasco I, Medrano V, Sánchez-Pérez RM, Moltó-Jordà JM, Matías-Guiu J. Diferencias entre pacientes con ictus isquémico españoles frente a centro y noreuropeos: un estudio de casos y controles. Rev Neurol 2005; 40: 193-8.
12. Witt BJ, Gami AS, Ballman KV, Brown RD Jr, Meverden RA, Jacobsen SJ, et al. The incidence of ischemic stroke in chronic heart failure: a meta-analysis. J Card Fail 2007; 13: 489-96.
13. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology. JAMA 2000; 283: 2008-12.
14. López-Pousa S, Villalta J, Llinás J. Incidencia de la enfermedad cerebrovascular en España: estudio de un área rural de Girona. Rev Neurol 1995; 23: 1074-80.
15. Matías-Guiu J. Epidemiological research on stroke in Spain. Population-based studies or use of estimates from the minimum basic data set? Rev Esp Cardiol 2007; 60: 563-4.
16. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular disease. Task Force on the European Society of Cardiology on Cardiovascular Disease Mortality and Morbility Statistics in Europe. Eur Heart J 1997; 18: 1231-48.
17. Bernal-Pacheco O, Román GC. Environmental vascular risk factors: new perspectives for stroke prevention. J Neurol Sci 2007; 262: 60-70.
18. Acha O, Hernández JL, Penado S, Cano M, Riancho JA. Risk factors and stroke among patients of different ages. Rev Clin Esp 2003; 203: 189-92.
19. Lindgren A, Lovkvist H, Hallstrom B, Hoglund P, Jonsson AC, Kristoffersson U, et al. Prevalence of stroke and vascular risk factors among first-degree relatives of stroke patients and control subjects. A prospective consecutive study. Cerebrovasc Dis 2005; 20: 381-7.
20. Lozano JV, Redón J, Cea-Calvo L, Fernández-Pérez C, Navarro J, Bonet A, et al, investigadores del estudio ERIC-HTA 2003. Risk assessment for a first stroke in Spanish hypertensive population in primary care. The ERIC-HTA study. Med Clin (Barc) 2005; 125: 247-51.
21. Amarenco P, Bogousslavsky J, Callahan A, Goldstein LB, Hennerici H, Rudolf AE, et al. High-dose atorvastatin after stroke or transient ischemic attack. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. N Engl J Med 2006; 355: 549-59.
22. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke 2006; 37: 1583-633.
23. Fuentes B, Díez-Tejedor E, Gil-Núñez A, Gil-Peralta A, Matías-Guiu J. Guía para el tratamiento preventivo de la isquemia cerebral. In Díez-Tejedor E, ed. Guía para el diagnóstico y tratamiento del ictus. Barcelona: Prous Science; 2006. p. 133-83.
24. Castilla-Guerra L, Fernández-Moreno MC, López-Chozas JM, Jiménez-Hernández MD. Estatinas y enfermedad cerebrovascular: nuevas perspectivas en la prevención del ictus. Rev Neurol 2007; 44: 95-100.
25. Evers S, Struijs JM, André J, Ament H, Marianne A, Van Genugten L, et al. International comparison of stroke cost studies. Stroke 2004; 35: 1209-15.
26. Truelsen T, Ekman M, Boysen G. Cost of stroke in Europe. Eur J Neurol 2005; 12 (Suppl 1): S78-84.
27. Hervás-Angulo A, Cabesés-Hita JM, Forcén-Alonso T. Costes del ictus desde la perspectiva social. Enfoque de incidencia retrospectiva con seguimiento a tres años. Rev Neurol 2006; 43: 518-25.
28. Carod-Artal FJ, Egido-Navarro JA, González-Gutierrez JL, Varela de Seijas E. Coste directo de la enfermedad cerebrovascular en el primer año de seguimiento. Rev Neurol 1999; 28: 1123-30.
29. Lamberts H, Wood M, Hofmans-Okkes IM. The International Classification of Primary Care in the European Community. With a multi-language layer. Oxford: Oxford University Press; 1993.
30. Thorvaldsen P, Asplund K, Kuulasmaa for the Who Monica Project. Stroke incidence, case fatality and mortality. Stroke 1995; 26: 361-7.
31. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
32. The Johns Hopkins ACG Case-mix System version 7.0-April, 2005. Baltimore: Johns Hopkins Bloomberg School of Public Health; 2005.
33. Weiner JP, Starfield BH, Steinwachs DM, Mumford LM. Development and application of a population-oriented measure of ambulatory care case-mix. Med Care 1991: 29: 452-72.
34. Grundy SM, Cleeman JI, Merz CNB, Brewer HB, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-39.
35. Guidelines for ATC classification. Oslo: Nordic Collaborating Centre for Drug Statistics Methodology; 1991.
36. Sever PS, Dahof B, Poulter NR, Wedel H, Beevers G, Caufield M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003; 361: 1149-58.
37. Colhoun HM, Betteridge DJ, Durrington PN, Neil HA, Livinstone SJ, Thomason MJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364: 685-96.
38. García-Cardona F, Molins-Pérez G, Farré-Pradell J, Martín-Sánchez A, Pane-Mena O, Gallego-Español R. Cost accountability in primary care: list of services. Aten Primaria 1995; 16: 141-5.
39. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ 2000; 320: 1197-200.
40. Sackett D, Rosenberg W, Gray J, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ 1996; 312: 71-2.
41. Castilla-Guerra L, Fernández-Moreno MC, López-Chozas JM. Tratamiento del paciente con ictus agudo en un área rural. Papel de la atención primaria. Rev Neurol 2004; 38: 997-8.
42. Mant J, McManus RJ, Hare R. Applicability to primary care of national clinical guidelines on blood pressure lowering for people with stroke: cross sectional study. BMJ 2006; 332: 635-7.
43. Muñoz-Arrondo R, Hernández-Hernández JL, Ramos-Estébanez C, Valle HA. Alcohol e ictus: asociación controvertida. Rev Neurol 2001; 33: 576-82.
44. Merino JG, Hachinski V. Demencia e ictus: la importancia de la enfermedad cerebral coexistente. Rev Neurol 2003; 36: 61-3.
45. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, Van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997; 349: 151-4.
46. Jeerakathil T, Johnson JA, Simpson SH, Majumdar SR. Short-term risk for stroke is doubled in persons with newly treated type 2 diabetes compared with persons without diabetes: a population-based cohort study. Stroke 2007; 38: 1739-43.
47. Carod-Artal FJ. Depresión postictus (I). Epidemiología, criterios diagnósticos y factores de riesgo. Rev Neurol 2006; 42: 169-75.
48. Amarenco P, Labreuche J, Lavallée PH, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis. Stroke 2004; 35: 2902-9.